| Date Filed | Type | Description |
| 08/25/2023 |
4
| Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 17,500 options to buy
@ $2.21, valued at
$38.7k
|
|
| 04/04/2023 |
4
| Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 175,000 options to buy
@ $0.34, valued at
$59.5k
|
|
| 03/03/2023 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.705, valued at
$68.2k
|
|
| 02/09/2023 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 01/25/2023 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Bought 50,000 shares
@ $1.4316, valued at
$71.6k
|
|
| 09/02/2022 |
4
| Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 30,000 options to buy
@ $1.43, valued at
$42.9k
|
|
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 02/02/2022 |
4
| Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 60,000 options to buy
@ $1.94, valued at
$116.4k
|
|
| 04/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2020 |
4
| Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 12,500 options to buy
@ $1.69, valued at
$21.1k
|
|
| 03/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2020 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Bought 4,000 shares
@ $13.94, valued at
$55.8k
|
|
| 06/12/2019 |
4
| Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 15,000 options to buy
@ $1.39, valued at
$20.9k
|
|
| 04/23/2019 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $11.099, valued at
$55.5k
|
|
| 04/22/2019 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $11.05, valued at
$55.3k
|
|
| 03/25/2019 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $13.41, valued at
$268.2k
|
|
| 02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 9,375 options to buy
@ $2, valued at
$18.8k
|
|
| 12/26/2018 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 9,330 shares
@ $5.01, valued at
$46.7k
|
|
| 12/20/2018 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $9.98, valued at
$49.9k
|
|
| 12/10/2018 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $11.26, valued at
$56.3k
|
|
| 04/20/2018 |
4
| Dietz Thomas John (Director) has filed a Form 4 on LEAP THERAPEUTICS, INC.|
Txns:
| Granted 11,250 options to buy
@ $7.66, valued at
$86.2k
|
|
| 03/16/2018 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Eiger BioPharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $9.5, valued at
$95k
|
|
| 02/16/2018 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 7,500 shares
@ $0
Granted 5,000 options to buy
@ $0 |
|
| 02/07/2018 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 2,100 shares
@ $14.22, valued at
$29.9k
|
|
|